What changed
New labels, trial publications, safety notices, shortage/access changes, and guideline updates that materially change how a topic should be explained.
The Glow Diary is built as a repeatable research engine, not a pile of one-off articles. Each weekly pass starts with source changes and reader questions, then decides which output is most useful: a guide refresh, a new article, a comparison-tool update, a newsletter issue, or a podcast/video segment.
Every loop must preserve the medical boundary: explain evidence, do not prescribe.
New labels, trial publications, safety notices, shortage/access changes, and guideline updates that materially change how a topic should be explained.
Recurring search/social questions translated into safer, source-backed article briefs and clinician-question prompts.
Older guides scheduled for re-review because a source, regulatory status, or consumer claim has moved.
The weekly article, newsletter angle, podcast outline, YouTube description, source list, and follow-up tool idea.
The same evidence packet should feed multiple reader surfaces without changing the claims.
FDA labels, FDA safety communications, DailyMed, MedlinePlus, agency pages
PubMed, trial publications, systematic reviews, ClinicalTrials.gov records
Retatrutide, CagriSema, amycretin, orforglipron, amylin, MASH/metabolic overlap
Search questions, correction requests, emails, comments, and repeated community confusion
Guide update, article brief, tool improvement, newsletter issue, podcast segment
One research packet, several safe and useful formats.
Answer one real user question with visible source notes, caveats, and clinician questions.
Turn repeated confusion into an education-only comparison, checklist, estimator, or timeline.
Package the research into a conversational episode with source links and medical-advice boundaries.